Find more items about these cancer types:

Leukemia

Old CML Drug Makes Comeback

(00:04:18) Elsevier Global Medical News, 2009 Dec 7, JS MacNeil

Dr. Jorge Cortes is Professor of Medicine at the University of Texas M.D. Anderson Cancer Center in Houston.

Omacetaxine mepesuccinate, an old drug with a new name, is making a comeback as a potential therapy for chronic myeloid leukemia with the T315I mutation that has proved resistant to imatinib and other tyrosine kinase inhibitors. 

See related videos to:
ASH 2009

Related Link:

News Article: CML Drug Makes Comeback as Treatment for Imatinib-Resistant Mutations »

Copyright © 2010 International Medical News Group
Subscribe Now »

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Most Viewed Video

Expert Gives Overview of Gamechangers at 2011 ASCO Annual Meeting
Elsevier Global Medical News, 2011 Jun 4
OncologySTAT Video Network

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration